Papillary muscle intervention vs mitral ring annuloplasty in ischemic mitral regurgitation

Linda R Micali1, Mohammad N Qadrouh1, Orlando Parise1

  • 1Department of Cardiothoracic Surgery, Maastricht University Hospital, Maastricht, The Netherlands.

Abstract

Insights

Combining papillary muscle intervention (PMI) with mitral ring annuloplasty (MRA) reduces mitral regurgitation (MR) recurrence compared to MRA alone. However, both approaches showed limited left ventricular reverse remodeling (LVRR).

Area of Science:

  • Cardiovascular Surgery
  • Interventional Cardiology
  • Cardiac Mechanics

Background:

  • Chronic ischemic mitral regurgitation (MR) is primarily caused by outward papillary muscle (PM) displacement, leading to leaflet tethering.
  • Papillary muscle intervention (PMI) combined with mitral ring annuloplasty (MRA) is a novel approach to address PM displacement and reduce MR recurrence.

Purpose of the Study:

  • To compare the efficacy of combined PMI and MRA versus MRA alone in managing chronic ischemic MR.
  • To evaluate the impact of different PMI techniques on clinical outcomes.

Main Methods:

  • A meta-analysis was performed comparing outcomes of combined PMI and MRA versus MRA alone.
  • Key outcomes assessed included MR recurrence and left ventricular reverse remodeling (LVRR).
  • Meta-regression was used to analyze the influence of specific PMI procedures.

Main Results:

  • Combined PMI and MRA demonstrated a statistically significant reduction in MR recurrence compared to MRA alone.
  • Both treatment groups showed a modest reduction in left ventricular diameters, but LVRR was less than 10% in both.
  • No significant difference in LVRR was observed between PM relocation/repositioning and papillary muscle approximation techniques.

Conclusions:

  • The combination of PMI and MRA is more effective in preventing MR recurrence than MRA alone.
  • Significant LVRR was not achieved with either combined therapy or MRA alone.
  • The specific type of PMI technique did not influence LVRR outcomes.

Related Concept Videos

Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
217
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
194
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
310
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
315
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
289
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
263